Ozeki Y, Takishima K, Mamiya G
Department of Biochemistry, National Defense Medical College, Saitama.
Jpn J Cancer Res. 1994 Aug;85(8):840-6. doi: 10.1111/j.1349-7006.1994.tb02956.x.
Levels of nm23-H1/nucleoside diphosphate kinase (NDP kinase) expression have been reported to correlate inversely with metastatic potential in some tumors but not in others. Whether or not nm23 gene product is associated with metastatic potential in lung cancer is not clear as yet. We therefore immunohistochemically examined the expression of nm23 gene products in primary lung adenocarcinomas according to cytologic subtypes in order to clarify the association of its expression with the clinical features of the disease. Seventy-two (64.9%) of the 111 lung adenocarcinomas were positive for nm23 protein. In lung adenocarcinoma of Clara cell type, high levels of nm23 expression were associated with advanced pathologic stage, positive lymph node status, and poorer prognosis (P < 0.05). However, no correlation with clinical outcome was observed in other cell types. Our data suggest that higher levels of nm23 expression are associated with tumor progression in lung adenocarcinoma of Clara cell type.
据报道,nm23-H1/核苷二磷酸激酶(NDP激酶)的表达水平在某些肿瘤中与转移潜能呈负相关,但在其他肿瘤中并非如此。nm23基因产物是否与肺癌的转移潜能相关,目前尚不清楚。因此,我们通过免疫组织化学方法,根据细胞亚型检测了原发性肺腺癌中nm23基因产物的表达,以阐明其表达与该疾病临床特征的关系。111例肺腺癌中,72例(64.9%)nm23蛋白呈阳性。在 Clara 细胞型肺腺癌中,nm23高表达与病理分期较晚、淋巴结阳性状态及预后较差相关(P < 0.05)。然而,在其他细胞类型中未观察到与临床结局的相关性。我们的数据表明,nm23高表达与 Clara 细胞型肺腺癌的肿瘤进展相关。